Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Envista Holdings Corporation (NVST) SEC Filings & Earnings Calls

EquiReason read 13 Envista Holdings Corporation SEC filings in the last 12 months. Latest: 8-K on 2026-09-17 — Envista announces 2026 Investor Day to provide strategy, growth initiatives, innovation priorities, and long-term financial objectives. No specific financial details disclosed..

Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason

NVSTEnvista Holdings CorporationFollow NVST — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
3.8B
P/E TTM
40.7
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

17 Sep 20268-K · 7.01Envista announces 2026 Investor Day to provide strategy, growth initiatives, innovation priorities, and long-term financial objectives. No specific financial details disclosed.SEC ↗
19 Aug 20268-K · 5.02, 8.01CEO Paul Keel appointed Chairman; base salary increased $200K to $1.3M; special $10M equity award (RSUs + PSUs tied to 4-year TSR). CFO Eric Hammes received $1.5M PSU award. Retention-focused compensation changes.open

Risks flagged

No material risk; compensation changes are standard retention tools.

“align with stockholder interest in retaining Mr. Keel’s service” · word for word
Read the original on SEC EDGAR ↗
5 Aug 20268-K · 2.02, 7.01Envista reports Q2 2026 core sales growth of 5.0%, adjusted EBITDA +28% to $108M, and raises FY2026 guidance for core sales, adjusted EBITDA, and adjusted EPS.earningsopen

Figures in the filing · each found in the filing text

Sales · Q2-2026$731M
Core Sales Growth · Q2-20265.0%
GAAP Diluted EPS · Q2-2026$0.33
Adjusted Diluted EPS · Q2-2026$0.41+58% y/y
GAAP Net Income · Q2-2026$54M
Adjusted EBITDA · Q2-2026$108M+29% y/y
Adjusted EBITDA Margin · Q2-202614.7%
Operating Cash Flow · Q2-2026$119M+34% y/y
Free Cash Flow · Q2-2026$105M+38% y/y
Share Repurchases · Q2-2026$59M

Guidance

FY26 core sales growth raised to 3.5%-4.5% from 2%-4%; FY26 adjusted EBITDA growth raised to 11%-14% from 7%-13%; FY26 adjusted diluted EPS raised to $1.50-$1.55 from $1.35-$1.45; FY26 free cash flow conversion ~100% (unchanged)

Guidance raised across core sales, adjusted EBITDA, and adjusted EPS, reflecting strong first-half performance and continued momentum.

Risks flagged

Macro uncertainty could impact future demand.

“In the context of macro uncertainty” · word for word

Tariff and trade policy risks mentioned in forward-looking statements.

“developments and uncertainties in trade policies and regulations including tariffs or other impositions on imported goods” · word for word
Read the original on SEC EDGAR ↗
5 Aug 202610-QQ2 2026 earnings: revenue +7.1%, net income +103.4%, strong margin expansion and tariff refund benefit.earningsopen

Figures in the filing · each found in the filing text

Sales · Q2-2026$731M+7% y/y
Net income · Q2-2026$54M+103% y/y
Free cash flow · H1-2026$89M
Operating cash flow · H1-2026$116M+30% y/y

Risks flagged

Tariff cost pressure

“Overall, we paid approximately $30 million in IEEPA related tariffs.” · word for word

Geopolitical conflict

“Geopolitical conflict and tensions...could have an adverse impact on our business.”
Read the original on SEC EDGAR ↗
3 Jun 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportSEC ↗
6 May 202610-QSales $706M (+14% y/y); Gross profit margin 55.3; Operating profit margin 8.9open

Figures in the filing · each found in the filing text

Sales · Q1-2026$706M+14% y/y
Gross profit margin · Q1-202655.3%
Operating profit margin · Q1-20268.9%
Net income · Q1-2026$39M+115% y/y
Core sales growth · Q1-20269.5%
Specialty Products & Technologies sales · Specialty Products & Technologies · Q1-2026$458M+14% y/y
Equipment & Consumables sales · Equipment & Consumables · Q1-2026$248M+14% y/y
Operating cash flow · Q1-2026$-3M
Capital expenditures · Q1-2026$13M+112% y/y

Risks flagged

Tariff cost pressure

“we have already experienced an increase in cost of sales due to higher tariffs.” · word for word

China demand weakness

“partially offset by lower demand in China.” · word for word

Geopolitical conflict risk

“Geopolitical conflict and tensions, such as Russia’s invasion of Ukraine, the ongoing events in the Middle East, including the conflict involving Iran, and the global response to these conflicts...could have an adverse impact on our business” · word for word
Read the original on SEC EDGAR ↗
6 May 20268-K · 2.02, 7.01Sales $706M; GAAP Net Income $39M; Adjusted EBITDA $99M (+25% y/y); Guidance: Core sales growth 2-4%; Adj. EBITDA growth 7-13%; Adj. EPS $1.35-$1.45earningsopen

Figures in the filing · each found in the filing text

Sales · Q1-2026$706M
GAAP Net Income · Q1-2026$39M
Adjusted EBITDA · Q1-2026$99M+25% y/y
Adjusted diluted EPS · Q1-2026$0.36+50% y/y

Guidance

Core sales growth 2-4%; Adj. EBITDA growth 7-13%; Adj. EPS $1.35-$1.45

Reaffirms FY2026 guidance; strong Q1 with margin expansion and buyback authorization.

Risks flagged

Macro uncertainty and tariff risks

“In the context of macro uncertainty ... developments and uncertainties in trade policies and regulations including tariffs”
Read the original on SEC EDGAR ↗
7 Apr 2026DEF 14AProxy statement filed for 2026 annual meeting, disclosing executive compensation, financial highlights, and governance practices.open

Figures in the filing · each found in the filing text

Total Revenue · FY2025$2.72B+8% y/y
Core Sales Growth · FY20256.5%
Net Income (Loss) · FY2025$47M
Adjusted EBITDA · FY2025$372M+26% y/y
Adjusted EBITDA Margin · FY202513.7%
Free Cash Flow · FY2025$231M-24% y/y
Operating Cash Flow · FY2025$276M-18% y/y
Adjusted Diluted EPS · FY2025$1.19+63% y/y

Guidance

2026 ICP metrics changed: adjusted EBITDA margin replaced with adjusted EBITDA ($); 2026 LTI values increased for some NEOs

2025 performance shows strong demand recovery and margin expansion; 2026 compensation changes reflect continued focus on growth and profitability.

Risks flagged

2023-2025 PSU zero payout indicates historical underperformance

“The Compensation Committee determined that 0% vesting of the 2023-2025 PSUs was aligned with financial performance during the three-year performance period and did not approve any vesting of the 2023-2025 PSUs.” · word for word

Free cash flow declined 23.7% in 2025

“Free Cash Flow* $230.9 (2025) vs $302.8 (2024)”
Read the original on SEC EDGAR ↗
12 Feb 202610-KInternational Sales Percentage 53; China Sales Percentage 7; Henry Schein Sales Percentage 12open

Figures in the filing · each found in the filing text

International Sales Percentage · Consolidated · FY202553.0%
China Sales Percentage · Consolidated · FY20257.0%
Henry Schein Sales Percentage · Consolidated · FY202512.0%
Total Debt · Consolidated · 2026-02-06$1.50B

Risks flagged

Tariff Cost Pressure

“We have already experienced an increase in costs attributable to higher tariffs.” · word for word

China VBP Risk

“China has implemented volume-based procurement policies... that has resulted in significant price cuts for medical and dental consumable products.” · word for word

Customer Concentration

“Henry Schein, which accounted for approximately 12% of our sales in 2025” · word for word

High Leverage

“We have outstanding indebtedness of approximately $1.5 billion as of February 6, 2026” · word for word

Discretionary Spending Sensitivity

“certain products and services that support discretionary dental procedures may be susceptible to changes in economic conditions.” · word for word
Read the original on SEC EDGAR ↗
5 Feb 20268-K · 2.02, 7.01Sales $751M; Core Sales Growth 10.8; GAAP Diluted EPS $0.20; Guidance: FY 2026 guidance: core sales growth 2-4%, adjusted EBITDA growth 7-13%, adjusted EPS $1.35-$1.45earningsopen

Figures in the filing · each found in the filing text

Sales · consolidated · Q4-2025$751M
Core Sales Growth · consolidated · Q4-202510.8%
GAAP Diluted EPS · consolidated · Q4-2025$0.20
Adjusted Diluted EPS · consolidated · Q4-2025$0.38+58% y/y
GAAP Net Income · consolidated · Q4-2025$33M
Adjusted EBITDA · consolidated · Q4-2025$111M+22% y/y
Adjusted EBITDA Margin · consolidated · Q4-202514.8%
Full Year Sales · consolidated · FY2025$2.72B
Full Year Core Sales Growth · consolidated · FY20256.5%
Full Year GAAP Diluted EPS · consolidated · FY2025$0.28

Guidance

FY 2026 guidance: core sales growth 2-4%, adjusted EBITDA growth 7-13%, adjusted EPS $1.35-$1.45

Initial 2026 guidance provided; Q4 and FY 2025 results exceeded expectations.

Risks flagged

Macro risks including inflation, interest rates, tariffs mentioned in forward-looking statements.

“Conditions in the U.S. and global economy, the impact of inflation and increasing interest rates, slower economic growth or recession.” · word for word
Read the original on SEC EDGAR ↗
30 Oct 202510-QQ3 2025 earnings: revenue +11.5% YoY, core sales +9.4%, gross margin +250bps, operating profit +175% YoY; net loss due to tax charge.earningsopen

Figures in the filing · each found in the filing text

Sales · Q3-2025$670M+12% y/y
Gross Profit Margin · Q3-202555.3%
Operating Profit · Q3-2025$58M+175% y/y
Net Income (Loss) · Q3-2025$-30M-470% y/y
Core Sales Growth (Non-GAAP) · Q3-20259.4%
Specialty Products & Technologies Sales · Specialty Products & Technologies · Q3-2025$432M+13% y/y
Equipment & Consumables Sales · Equipment & Consumables · Q3-2025$238M+9% y/y
Operating Cash Flow · 9M-2025$168M-18% y/y
Free Cash Flow · 9M-2025$139M-23% y/y
Cash and Cash Equivalents · 2025-09-26$1.13B

Risks flagged

Tariff cost pressure on margins

“While we expect to largely offset the impact of the existing tariffs with mitigating actions including supply chain adjustments, pricing strategies, and cost management, we have already experienced an increase in cost of sales attributable to higher tariffs.” · word for word

China demand weakness

“Geographically, sales for both the three and nine months ended September 26, 2025 were positively impacted by higher sales from North America and Europe; partially offset by lower demand in China.” · word for word

High effective tax rate volatility

“Our effective tax rate of 160.7% and 88.2% for the three and nine months ended September 26, 2025 differed from the comparable periods in 2024 primarily due to the impact of nondeductible impairment charges for goodwill and intangible assets in 2024 and primarily due to a change in the indefinite reinvestment assertion related to the restructuring of a forei” · word for word

Foreign exchange exposure

“Any future weakening of the U.S. dollar against major currencies would positively impact our sales and results of operations for the remainder of the year, and any strengthening of the U.S. dollar against major currencies would adversely impact our sales and results of operations for the remainder of the year.” · word for word
Read the original on SEC EDGAR ↗
29 Oct 20258-K · 2.02, 7.01Sales $670M; Core Sales Growth 9.4; GAAP Diluted EPS $-0.18; Guidance: Core sales growth ~4% (from 3-4%), adjusted EPS $1.10-$1.15 (from $1.05-$1.15)earningsopen

Figures in the filing · each found in the filing text

Sales · consolidated · Q3-2025$670M
Core Sales Growth · consolidated · Q3-20259.4%
GAAP Diluted EPS · consolidated · Q3-2025$-0.18
Adjusted Diluted EPS · consolidated · Q3-2025$0.32+167% y/y
GAAP Net Loss · consolidated · Q3-2025$-30M
Adjusted EBITDA · consolidated · Q3-2025$97M+76% y/y
Adjusted EBITDA Margin · consolidated · Q3-202514.5%
YTD Sales · consolidated · 9M-2025$1.97B
YTD Core Sales Growth · consolidated · 9M-20255.0%
YTD GAAP Diluted EPS · consolidated · 9M-2025$0.08

Guidance

Core sales growth ~4% (from 3-4%), adjusted EPS $1.10-$1.15 (from $1.05-$1.15)

Raised full-year 2025 guidance; strong Q3 beat with 9.4% core growth and 540bps margin expansion.

Risks flagged

GAAP net loss due to tax charge from intercompany loan restructuring.

“GAAP Net Loss was $30 million, as a result of a tax charge from the restructuring of certain intercompany loans.” · word for word

Macro risks including inflation, interest rates, tariffs mentioned in forward-looking statements.

“Conditions in the U.S. and global economy, the impact of inflation and increasing interest rates, slower economic growth or recession.” · word for word
Read the original on SEC EDGAR ↗
29 Oct 20258-K · 7.01Donated goods and services $2M; Safety incident rate reduction 13open

Figures in the filing · each found in the filing text

Donated goods and services · FY2024$2M
Safety incident rate reduction · FY202413.0%

Risks flagged

No material risks disclosed; forward-looking statements are boilerplate.

“Standard forward-looking statements with no specific risk updates.”
Read the original on SEC EDGAR ↗

Envista Holdings Corporation — questions

What did Envista Holdings Corporation file recently?
13 SEC filings in the last 12 months. Latest: 8-K on 2026-09-17 — Envista announces 2026 Investor Day to provide strategy, growth initiatives, innovation priorities, and long-term financial objectives. No specific financial details disclosed.

Every figure on this page comes from Envista Holdings Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.